These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860 [TBL] [Abstract][Full Text] [Related]
5. Non-invasive models for predicting histology in patients with chronic hepatitis B. Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322 [TBL] [Abstract][Full Text] [Related]
6. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. Kannangai R; Vivekanandan P; Netski D; Mehta S; Kirk GD; Thomas DL; Torbenson M J Clin Virol; 2007 Jun; 39(2):101-5. PubMed ID: 17452002 [TBL] [Abstract][Full Text] [Related]
7. [Morphological liver changes of chronic hepatitis C in antiretroviral-naive HIV-infected patients]. Grabczewska E; Pawłowska M Przegl Epidemiol; 2005; 59(2):423-30. PubMed ID: 16190550 [TBL] [Abstract][Full Text] [Related]
8. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810 [TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C. Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561 [TBL] [Abstract][Full Text] [Related]
10. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175 [TBL] [Abstract][Full Text] [Related]
11. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597 [TBL] [Abstract][Full Text] [Related]
12. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B. Tsochatzis E; Papatheodoridis GV; Manolakopoulos S; Tiniakos DG; Manesis EK; Archimandritis AJ Scand J Gastroenterol; 2009; 44(6):752-9. PubMed ID: 19296398 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection. Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C. Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583 [TBL] [Abstract][Full Text] [Related]
15. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Lok AS; Ghany MG; Goodman ZD; Wright EC; Everson GT; Sterling RK; Everhart JE; Lindsay KL; Bonkovsky HL; Di Bisceglie AM; Lee WM; Morgan TR; Dienstag JL; Morishima C Hepatology; 2005 Aug; 42(2):282-92. PubMed ID: 15986415 [TBL] [Abstract][Full Text] [Related]
16. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection]. Stránský J; Ryzlová M; Striteský J; Horák J Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138 [TBL] [Abstract][Full Text] [Related]
17. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection. Attallah AM; Toson el-SA; El-Waseef AM; Abo-Seif MA; Omran MM; Shiha GE Clin Chim Acta; 2006 Jul; 369(1):66-72. PubMed ID: 16545356 [TBL] [Abstract][Full Text] [Related]
18. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661 [TBL] [Abstract][Full Text] [Related]
19. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study. Elsebae MM; Abu-Zekri NB Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898 [TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]